AstraZeneca is putting the pedal to the metal to drive up early detection of prostate cancer. | AstraZeneca is putting the ...

Following the presentation titled ‘Discovering Targeted Glue™ degraders with Amphista's Eclipsys® platform’, Simon Gilbert, PhD, Presenting Author and Associate Director Discovery Biology at Amphista ...

Drugmakers Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis all sued the government ... the president and CEO of hospital lobby 340B Health, in a statement Friday. Testoni added that rebates ...

The Immunotherapy Drugs Market is set to grow from USD 257.60 billion in 2024 to USD 486.36 billion by 2030, with a CAGR of ...

The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...

and through the alliance the companies plan to apply some of the start-up's enterprise software to some of Novartis’ most important trials. NeuroFlow wins digital health challenge NeuroFlow ...

An Indiana health system has refreshed its brand as it prepares to open a new hospital. Batesville, Ind.-based Margaret Mary Health unveiled a new logo in May that will roll out across its locations ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

Semiconductor EDA Software Market is Segmented by Type (Electronic Circuit Design and Simulation, PCB Design, IC Design), by Application (Automotive, Industrial, Consumer Electronics, Communication, ...